Medicare Enrolled

Dr. Charles Kuzma, M.D.

Hematology & Oncology · Pinehurst, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
220 PAGE RD, Pinehurst, NC 28374
9107153500
Registered in NPPES since 2006
NPI: 1063469856 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kuzma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuzma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kuzma

Dr. Charles Kuzma is a hematology & oncology specialist in Pinehurst, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuzma performed 695 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kuzma received a total of $69,287 from 55 pharmaceutical and/or device companies across 358 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kuzma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 26% volume in NC $69,287 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
695
Medicare services
Top 26% in NC for hematology & oncology
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
325 $68 $223
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
240 $108 $330
New patient office visit, complex (60-74 min) 48 $131 $540
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
47 $58 $203
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
22 $23 $76
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
13 $49 $413
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$69,287
Total received (2018-2024)
Avg $9,898/year across 7 years
Top 9% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
358
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17,091
2023
$6,255
2022
$10,766
2021
$10,481
2020
$8,646
2019
$10,818
2018
$5,231

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$6,984
Genentech USA, Inc.
$4,899
Exelixis Inc.
$3,292
BeiGene USA, Inc.
$373
Novartis Pharmaceuticals Corporation
$210
PFIZER INC.
$142
Celgene Corporation
$124
Eisai Inc.
$107
SEAGEN INC.
$100
Merck Sharp & Dohme LLC
$79
Agios Pharmaceuticals, Inc.
$75
Mirati Therapeutics, Inc.
$60
ARRAY BIOPHARMA INC
$56
Gilead Sciences, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$53
Incyte Corporation
$52
Deciphera Pharmaceuticals Inc.
$48
Daiichi Sankyo Inc.
$47
Astellas Pharma US Inc
$36
SERVIER PHARMACEUTICALS LLC
$36
Takeda Pharmaceuticals U.S.A., Inc.
$27
Stemline Therapeutics Inc.
$25
Lilly USA, LLC
$24
Rigel Pharmaceuticals, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$21
Janssen Biotech, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Aveo Pharmaceuticals, Inc.
$20
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 88.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$16,100
Genentech USA, Inc.
$8,887
Incyte Corporation
$8,534
Coherus Biosciences Inc.
$5,727
GlaxoSmithKline, LLC.
$5,138
Athenex Pharmaceutical Division, LLC
$3,675
Exelixis Inc.
$3,440
Karyopharm Therapeutics Inc.
$2,325
Bayer HealthCare Pharmaceuticals Inc.
$2,066
Kite Pharma, Inc.
$2,000
Epizyme, Inc.
$1,441
Celgene Corporation
$1,385
GENZYME CORPORATION
$960
Genentech, Inc.
$880
BeiGene USA, Inc.
$705
BeiGene, Ltd.
$665
Astellas Pharma US Inc
$536
Lilly USA, LLC
$457
SANOFI-AVENTIS U.S. LLC
$450
Novartis Pharmaceuticals Corporation
$325
Takeda Pharmaceuticals U.S.A., Inc.
$300
PFIZER INC.
$267
Foundation Medicine, Inc.
$250
JAZZ PHARMACEUTICALS INC.
$249
Merck Sharp & Dohme LLC
$242
Seagen Inc.
$211
Merck Sharp & Dohme Corporation
$182
Eisai Inc.
$153
COMSORT, Inc
$150
Alexion Pharmaceuticals, Inc.
$142
Seattle Genetics, Inc.
$112
E.R. Squibb & Sons, L.L.C.
$110
United Therapeutics Corporation
$100
SEAGEN INC.
$100
Daiichi Sankyo Inc.
$99
Amgen Inc.
$89
SERVIER PHARMACEUTICALS LLC
$77
Agios Pharmaceuticals, Inc.
$75
Nevro Corp.
$69
Gilead Sciences, Inc.
$66
TESARO, Inc.
$61
Mirati Therapeutics, Inc.
$60
ARRAY BIOPHARMA INC
$56
Regeneron Healthcare Solutions, Inc.
$55
Deciphera Pharmaceuticals Inc.
$48
EISAI INC.
$40
EMD Serono, Inc.
$40
Janssen Biotech, Inc.
$33
Stemline Therapeutics Inc.
$25
Rigel Pharmaceuticals, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Sun Pharmaceutical Industries Inc.
$23
Puma Biotechnology, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Aveo Pharmaceuticals, Inc.
$20
Top 3 companies account for 48.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · ELITEK · ELZONRIS · Enhertu · FOTIVDA · FOUNDATIONONE LIQUID · Fabhalta · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · NO PRODUCT DISCUSSED · OJJAARA · OPDIVO · Oral Paclitaxel · PADCEV · PLUVICTO · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SCEMBLIX · SPRYCEL · Senza Spinal Cord Stimulation System · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · TUKYSA · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · UNITUXIN · Ultomiris · VELCADE · VERZENIO · VOTRIENT · Vitrakvi · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · YONSA · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Pinehurst?
Compare hematology & oncology specialists in the Pinehurst area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
6
County median income
$82,837
Nearest hospital to ZIP centroid (approximate)
FIRSTHEALTH MOORE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kuzma is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NC), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kuzma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kuzma performed 325 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kuzma receive payments from pharmaceutical companies?
Yes. Dr. Kuzma received a total of $69,287 from 55 companies across 358 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuzma's costs compare to other hematology & oncology specialists in Pinehurst?
Dr. Kuzma's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuzma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →